How is Carfilzomib reimbursed?

Carfilzomib (Carfilzomib) is an important anti-cancer drug mainly used to treat multiple myeloma (Multiple Myeloma), which is a malignant bone marrow cancer, also known as plasma cell cancer. Carfilzomib is a proteasome inhibitor and belongs to the protease inhibitor drug class. Its main function is to inhibit the protein degradation process in the proteasome.

Carfilzomib has been launched in China and is included in medical insurance. Patients can purchase it domestically at a price of around 8,000 to 9,000 yuan. For specific reimbursement policies and prices please consult the local hospital pharmacy. In foreign countries, the original drug of carfilzomib is mainly available, and the cheaper version is the European version of the original drug, which costs around 5,000. And the medicinal ingredients and efficacy are the same as those of domestic original medicines.

Carfilzomib works by interfering with the proteasome, a complex protein degradation system within cells. By specifically inhibiting specific subunits of the proteasome, carfilzomib causes the accumulation of proteins within multiple myeloma cells, ultimately leading to the death of these cancer cells. This mechanism allows carfilzomib to effectively control the proliferation and spread of tumor cells.

Carfilzomib is usually given to patients as an intravenous injection, often in combination with other drugs, such as hormone therapy and immunomodulators, as a treatment for multiple myeloma. It is often used in patients who have received other treatments but whose disease is still progressing, or at the time of initial diagnosis to help control the progression of the disease.

Although carfilzomib has significant efficacy in the treatment of multiple myeloma, it can also cause a range of side effects, including cardiotoxicity, pulmonary toxicity, hypertension, bleeding, nausea, vomiting, diarrhea, anemia, and renal impairment. Therefore, doctors need to closely monitor the patient's health while using carfilzomib to ensure the safety and effectiveness of the treatment.